Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X006981 | — |
No additional AE.; HCP calling to report that patient received post expiry dose of VARIVAX. No Previous TE; This spontaneous report was received from a nurse (Licensed Practical Nurse [L.P.N.]) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 17-Mar-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) single dose (lot #X006981 that was verified to be valid lot # with provided end established expiration date: 07-Mar-2025) administered for prophylaxis (exact dose, dose number, anatomical location and route of administration were not provided); reconstituted with sterile diluent (MERCK STERILE DILUENT), Solution for injection (expiration date, and lot # were not reported) (Expired product administered). No previous temperature excursion (TE) was reported. No additional adverse event (AE) was reported (no adverse event).
Sterile diluent